Peregrine Pharmaceuticals reported $2.53M in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US USD -74102000 17.39M
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 2.29B 796M
Biocryst Pharmaceuticals BCRX:US USD -71466000 30.47M
Celldex Therapeutics CLDX:US USD -26487000 297K
Eli Lilly And LLY:US USD 2.04B 38.3M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Immunogen IMGN:US USD -57790000 19.96M
Intrexon XON:US USD -22168000 14.47M
Karyopharm Therapeutics KPTI:US USD -38433000 2.15M
Macrogenics MGNX:US USD 12.8M 37.61M
Mannkind MNKD:US USD -17947000 3.51M
Merk MRK:US USD 4.89B 560M
Minerva Neurosciences NERV:US USD -6726000 175K
Newlink Genetics NLNK:US USD -8260000 1.01M
Novartis NOVN:VX USD 3.86B 195M
Novavax NVAX:US USD -184509000 18.37M
Peregrine Pharmaceuticals PPHM:US USD 2.53M 5.77M
Repligen RGEN:US USD 45.73M 7.94M
Roche Holding ROG:VX 8.85B 3.26B
Xencor XNCR:US USD -12457000 19.21M